Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

ETHICON ENDO-SURGERY

Ethicon Endo-Surgery, Inc. a subsidiary of the Johnson & Johnson group of companies, develops, manufactures, and mark... read more Featured Products: More products

Download Mobile App




Magnetic Bracelet Device Effectively Manages Reflux

By HospiMedica International staff writers
Posted on 30 Oct 2018
A bracelet made of miniature magnetic beads helps relieve symptoms of gastroesophageal reflux disease (GERD) and improves patient’s quality of life (QOL).

A product of Ethicon Endo-Surgery (Ethicon, Cincinnati, OH, USA), the LINX Reflux Management System is made of a series of titanium beads, each with its own magnetic core, connected together with independent titanium wires so as to form a ring-shaped magnetic sphincter augmentation (MSA) device. More...
The device is implanted during a laparoscopic procedure and wrapped around the lower esophageal sphincter (LES). The magnetic forces between the beads help keep a weakened LES closed, preventing a reversed flow of stomach contents.

When eating, the magnetic force between the beads is overcome by the high pressures formed by the body’s swallowing forces, and the device expands to accommodate ingestion of food or liquid. Once the food passes though the LES, the device returns to its resting state. The reversible LINX MSA device can thus provide a simple and effective treatment option for GERD, preserving gastric anatomy, establishing normal physiological function, and relieving patients of dependence on medication.

In a new study comparing the LINX device to proton pump inhibitors (PPIs; the standard of medical care for GERD treatment), 89% of LINX patients achieved relief from moderate to severe regurgitation, compared to 10% of those treated with twice-daily omeprazole; 81% had an improved QOL, compared to 8% of the omeprazole patients; and 81% of LINX patients reported satisfaction with their current condition, versus just two percent of patients treated with twice-daily omeprazole.

“Patients experiencing regurgitation, despite proton-pump inhibitor therapy, actually did extremely well with an anti-reflux procedure, magnetic sphincter augmentation, using the LINX device,” said study co-author gastrointestinal surgeon Reginald Bell, MD, of the Institute of Esophageal and Reflux Surgery (Englewood, CO, USA). “When the physiology of GERD is recognized – that it is due to a mechanical defect in the sphincter – it makes sense that patients would indeed respond to the procedure.”

In GERD patients, the esophageal sphincter is weakened and does not close tightly, allowing digestive juices to return and irritate the esophageal lining. Treatment options include lifestyle changes and medications, such as over-the-counter antacids, PPIs, and a surgical fundoplication, in which the excess stomach tissue is folded around the esophagus and sewn in place to strengthen the LES.


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.